Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01203787
What this trial is testing

Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Florida 120
Testing effectiveness (Phase 2)Study completedNCT01934829
What this trial is testing

Urea Cream Treatment Sorafenib-Associated HSFR in HCC

Who this might be right for
Hepatocellular Carcinoma
Chinese Anti-Cancer Association 871
Not applicableUnknownNCT03609268
What this trial is testing

Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma

Who this might be right for
Recurrent Hepatocellular CarcinomaMicrowave AblationStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 110
Not applicableStudy completedNCT02272504
What this trial is testing

A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers

Who this might be right for
CirrhosisChronic Liver Diseases
Wako Life Sciences 2,500
Not applicableLooking for participantsNCT04745390
What this trial is testing

Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Metastases
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 110
Testing effectiveness (Phase 2)Study completedNCT01850368
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Korea Cancer Center Hospital 35
Not applicableStudy completedNCT06899763
What this trial is testing

Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)MASLD-HCCHCV_HCC
Fondazione IRCCS Policlinico San Matteo di Pavia 6
Not applicableEnded earlyNCT02585687
What this trial is testing

Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hospices Civils de Lyon 28
Not applicableLooking for participantsNCT04221893
What this trial is testing

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Who this might be right for
Stage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more
University of California, San Francisco 28
Large-scale testing (Phase 3)UnknownNCT04167293
What this trial is testing

Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT06679985
What this trial is testing

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 72
Not applicableEnded earlyNCT02908048
What this trial is testing

Extracellular RNA Markers of Liver Disease and Cancer

Who this might be right for
Hepatocellular CarcinomaBiliary Tract CancerCirrhosis+1 more
Mayo Clinic 1,865
Large-scale testing (Phase 3)UnknownNCT03338647
What this trial is testing

SBRT or TACE for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
University of Aarhus 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05897138
What this trial is testing

Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses

Who this might be right for
Hepatocellular Carcinoma
Fujian Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05451043
What this trial is testing

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Who this might be right for
Pancreatic CancerHepatocellular CancerBiliary Tract Cancer+1 more
AHS Cancer Control Alberta 62
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Testing effectiveness (Phase 2)Ended earlyNCT01032850
What this trial is testing

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
New Mexico Cancer Research Alliance 15
Testing effectiveness (Phase 2)Study completedNCT04945720
What this trial is testing

Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 30
Not applicableLooking for participantsNCT06061276
What this trial is testing

BTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Who this might be right for
Liver DiseasesHepatocellular CarcinomaImmunotherapy+2 more
Sun Yat-sen University 40
Not applicableNot Yet RecruitingNCT07117279
What this trial is testing

A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Tongji Hospital 120
Next Page